Tidal Investments’s Aspire Biopharma ASBP Stock Holding History

Tidal Investments’s Portfolio ASBP Stock Details ASBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8	Closed	-$112K	–	1953
2024 Q1	$112K	Sell	8 -1	-11%	-$13.2K	﹤0.01%	1608
2023 Q4	$114K	Hold	9	–	–	﹤0.01%	1382
2023 Q3	$130K	Buy	+9	New	+$116K	﹤0.01%	1254

Other funds holding ASBP

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tidal Investments's ASBP Position: Q2 2024 in Review

Tidal Investments sold out of Aspire Biopharma (ASBP) in Q2 2024, closing a stake of 8 shares — an estimated $112K sold.

Tidal Investments first reported a position in ASBP in Q3 2023 and held it in 3 quarters. The position peaked at $130K in Q3 2023. 3 funds tracked by Wall St. Rank hold ASBP as of Q2 2024.

Tidal Investments reported no remaining Aspire Biopharma position as of Q2 2024 after selling out during the quarter.
Tidal Investments sold 8 Aspire Biopharma shares in Q2 2024, an estimated $112K.
Tidal Investments first reported a position in Aspire Biopharma in Q3 2023 and held it in 3 quarters.
Tidal Investments's Aspire Biopharma position peaked at $130K in Q3 2023.
3 funds tracked by Wall St. Rank held Aspire Biopharma as of Q2 2024.

Based on Tidal Investments's 13F filing for Q2 2024, filed 14 Aug 2024.